Pharmacies and Drugmakers United to Prevent the Second Wave of COVID-19

Pharmacies and Drugmakers United to Prevent the Second Wave of COVID-19
SHARE

The upcoming presumed second wave of COVID-19 has had the pharmacy chains thoroughly prepare for plenty of vaccines. In this way, the officials hope to prevent this second wave of cases from coming in October.

CVS Health Corp, the biggest American pharmacy chain, has declared that its staff is working day and night to ensure that the chain can provide vaccines in advance, which would help customers to protect themselves from seasonal influenza. In the meantime, the biggest competitor, Rite Aid Corp, has increased its stocks of vaccines by 40% to meet the demand.

A recent study conducted on 4,428 adults in May has shown that approximately 60% of them are more likely to get a flu vaccine in the fall. During normal conditions, less than 50% of the Americans get vaccinated, even if the US Centers for Disease Control and Prevention declared that it is vital to vaccinate, starting from 6 months old.

Even though getting vaccinating can only prevent individuals from contracting seasonal flu, it might prove efficient for hospitals, which would not be overwhelmed with patients during the second wave of coronavirus outburst. At the moment, Americans can theoretically get their vaccine at no cost. However, vaccine clinics offer it for $40, while the global revenue coming from influenza vaccines earns up to $5 billion.

The experts have underlined the importance of finding personalized ways of vaccinating as many people as possible to prevent them from reaching their doctors during October, as well as getting infected with COVID-19. Dr. Nancy Messonnier, director of CDC National Center for Immunization and Respiratory Disease, has declared that his primary objective is to sell every vaccine produced.

American’s skepticism towards getting vaccinated is caused by the fact that the target market chosen for tests is not as reliable as it should be. According to researchers, a vaccine protects around 40% of those injected, since the developing process of the medicine does not cater to the exact dominant flu strains during the season.

 

 


SHARE

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.